Q9992 Insurance Policy Changes

HCPCS Q9992 is officially defined as "Injection, buprenorphine extended-release (sublocade), greater than 100 mg." HCPCS Q9992 is referenced in 4 tracked payer policy changes from Aetna, Oregon Health Plan, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q9992 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Related

All billing codesJ35909921399212992029921499203

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert